Synthetic genomics: options for governance

MS Garfinkel, D Endy, GL Epstein… - Industrial …, 2007 - liebertpub.com
• III-6. Broaden IBC review responsibilities, plus enhance enforcement of compliance with
biosafety guidelines. The report presents no recommendations. A summary table of our …

Functional Expression and RNA Binding Analysis of the Interferon-Induced, Double-Stranded RNA-Activated, 68,000-Mr Protein Kinase in a Cell-Free System

…, M Wambach, ML Wong, M Garfinkel… - … and cellular biology, 1991 - Taylor & Francis
Eukaryotic viruses have devised numerous strategies to downregulate activity of the
interferon-induced, double-stranded (dsRNA)-activated protein kinase (referred to as p68 on the …

[HTML][HTML] Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5'-untranslated region.

MS Garfinkel, MG Katze - Journal of Biological Chemistry, 1993 - Elsevier
In cells infected by influenza virus type A, host cell protein synthesis declines rapidly and
dramatically, while influenza viral protein synthesis occurs efficiently throughout infection. …

[PDF][PDF] Science policy in its social context

…, G Foladori, N Invernizzi, MS Garfinkel - Philosophy …, 2004 - sciencepolicy.colorado.edu
Public support of science is justified by three primary instrumental rationales: scientific
advance is necessary to create new wealth; scientific advance is necessary to solve particular …

[HTML][HTML] Bottlenecks and opportunities for synthetic biology biosafety standards

L Pei, M Garfinkel, M Schmidt - Nature communications, 2022 - nature.com
The lack of innovative standards for biosafety in synthetic biology is an unresolved policy
gap that limits many potential applications in synthetic biology. We argue that a massive …

Synthetic biology and the US biotechnology regulatory system: Challenges and options

SR Carter, M Rodemeyer, MS Garfinkel, RM Friedman - 2014 - osti.gov
Challenges and Options Page 1 SYNTHETIC BIOLOGY AND THE US BIOTECHNOLOGY
REGULATORY SYSTEM: Challenges and Options Sarah R. Carter, Ph.D., J. Craig Venter …

[PDF][PDF] Stem cell research and applications: monitoring the frontiers of biomedical research

A Chapman, M Frankel, M Garfinkel… - 1999 - scholarworks.iupui.edu
Michele S. … Michele S. Garfinkel, Ph.D., is a Program Assistant in the AAAS Scientific
Freedom, Responsibility and Law Program. Prior to joining AAAS, she was a post-doctoral …

Cloning and Characterization of peter pan, a NovelDrosophila Gene Required for Larval Growth

JC Migeon, MS Garfinkel, BA Edgar - Molecular biology of the cell, 1999 - Am Soc Cell Biol
We identified a new Drosophila gene, peter pan (ppan), in a screen for larval growth–defective
mutants. ppan mutant larvae do not grow and show minimal DNA replication but can …

[PDF][PDF] The multiplier approach to the money supply process: a precautionary note

DL Thornton, M Garfinkel - Federal Reserve Bank of St. Louis Review …, 1991 - academia.edu
48 factors and if, conditional on these factors, these demands are strictly proportional. From
an empirical perspective, this condition is necessary but not sufficient; the degree to which …

Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed ds RNA-activated …

GN Barber, J Tomita, MS Garfinkel, E Meurs… - Virology, 1992 - Elsevier
The P68 protein kinase (referred to as P68 based on its M r of 68,000 in human cells) is a
serine/threonine kinase induced by interferon treatment and activated by dsRNAs. The kinase …